Andrew Giovanni

2.0k total citations
23 papers, 1.7k citations indexed

About

Andrew Giovanni is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Andrew Giovanni has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 7 papers in Neurology and 5 papers in Molecular Biology. Recurrent topics in Andrew Giovanni's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Neurological disorders and treatments (4 papers). Andrew Giovanni is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Neurological disorders and treatments (4 papers). Andrew Giovanni collaborates with scholars based in United States, Canada and France. Andrew Giovanni's co-authors include Patricia K. Sonsalla, Richard E. Heikkila, Elizabeth Keramaris, Ruth S. Slack, David S. Park, Beth‐Anne Sieber, Heeseog Kang, Fernando Camacho, Erica Vielhaber and William J. Hurst and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Andrew Giovanni

23 papers receiving 1.7k citations

Peers

Countries citing papers authored by Andrew Giovanni

Since Specialization

Citations

This map shows the geographic impact of Andrew Giovanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Giovanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Giovanni more than expected).

Fields of papers citing papers by Andrew Giovanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Giovanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Giovanni. The network helps show where Andrew Giovanni may publish in the future.

Co-authorship network of co-authors of Andrew Giovanni

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Giovanni. A scholar is included among the top collaborators of Andrew Giovanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Giovanni. Andrew Giovanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of pathways that regulate circadian rhythms using a larval zebrafish small molecule screen 2019 ·Scientific Reports ·Eric A. Mosser, Cindy N. Chiu, T. Katherine Tamai, Tsuyoshi Hirota, (unknown), May Hui, (unknown), Chanpreet Singh, Andrew Giovanni, Steve A. Kay, David A. Prober	28
2	Design and synthesis of D1 agonist/D2 antagonist for treatment of schizophrenia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Andrew Giovanni, Joachim E. Roehr, (unknown), Kent Neuenschwander, (unknown), (unknown), Larry D. Davis, (unknown)	4
3	Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group 2012 ·ACS Medicinal Chemistry Letters ·Guyan Liang, Xin Chen, Suzanne C. Aldous, (unknown), Shujaath Mehdi, Elaine A. Powers, Andrew Giovanni, Sathapana Kongsamut, (unknown), Ying Zhang, Rachel Wang, Zhongli Gao, (unknown), Larry R. McLean, Isabelle Morize	11
4	Control of Mammalian Circadian Rhythm by CKIε-Regulated Proteasome-Mediated PER2 Degradation 2005 ·Molecular and Cellular Biology ·Erik J. Eide, (unknown), Heeseog Kang, Peter Woolf, William J. Hurst, Fernando Camacho, Erica Vielhaber, Andrew Giovanni, David M. Virshup	416
5	In vitro and in vivo models for the evaluation of potent inhibitors of male rat 17α-hydroxylase/C17,20-lyase 2003 ·The Journal of Steroid Biochemistry and Molecular Biology ·(unknown), Pascal Bonnet, (unknown), S. Cardinali, Antoine Rivière, Andrew Giovanni, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rémi Delansorne	12
6	Guanosine 3′,5′-cyclic monophosphate mediated inhibition of cell death induced by nerve growth factor withdrawal and β-amyloid: protective effects of Propentofylline 2000 ·Neuroscience ·(unknown), Andrew Giovanni	36
7	E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3 2000 ·Journal of Biological Chemistry ·Andrew Giovanni, Elizabeth Keramaris, Erick J. Morris, Sheng‐Tao Hou, Michael J. O’Hare, Nick Dyson, George S. Robertson, Ruth S. Slack, David S. Park	182
8	Involvement of Cell Cycle Elements, Cyclin-dependent Kinases, pRb, and E2F·DP, in B-amyloid-induced Neuronal Death 1999 ·Journal of Biological Chemistry ·Andrew Giovanni, (unknown), Elizabeth Keramaris, Ruth S. Slack, David S. Park	209
9	Amyloid β-peptides inhibit Na/K-ATPase: tissue slices versus primary cultures 1998 ·Brain Research Bulletin ·Gina M. Bores, Craig P. Smith, (unknown), Andrew Giovanni	19
10	Anti‐Obsessional and Antidepressant Profile of Besipirdine 1997 ·CNS Drug Reviews ·Craig P. Smith, (unknown), Roy Corbett, Roger D. Porsolt, Joachim E. Roehr, Gina M. Bores, Andrew Giovanni, Mark R. Szewczak, Douglas K. Rush, Lisandra L. Martin, Joseph Klein, (unknown), (unknown), (unknown), Francis P. Huger, Sathapana Kongsamut	9
11	Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies 1996 ·Behavioural Brain Research ·Ruiqian Wan, Andrew Giovanni, (unknown), Roy Corbett	86
12	Modification of an Enzymatic Glutathione Assay for the Microtiter Plate and the Determination of Glutathione in Rat Primary Cortical Cells 1996 ·Toxicology Methods ·Janet Clarke, (unknown), Andrew Giovanni, David Brewster	4
13	Estimating Hydroxyl Radical Content in Rat Brain Using Systemic and Intraventricular Salicylate: Impact of Methamphetamine 1995 ·Journal of Neurochemistry ·Andrew Giovanni, Li Liang, Teresa G. Hastings, Michael J. Zigmond	175
14	Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Andrew Giovanni, Patricia K. Sonsalla, Richard E. Heikkila	74
15	Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Andrew Giovanni, Beth‐Anne Sieber, Richard E. Heikkila, Patricia K. Sonsalla	103
16	MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in Rats 1992 ·Journal of Neurochemistry ·Patricia K. Sonsalla, Gail D. Zeevalk, Lawrence Manzino, Andrew Giovanni, William J. Nicklas	103
17	Characteristics of Dopaminergic Neurotoxicity Produced by MPTP and Methamphetamine^a 1992 ·Annals of the New York Academy of Sciences ·Patricia K. Sonsalla, Andrew Giovanni, Beth‐Anne Sieber, (unknown), Lawrence Manzino	33
18	Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. 1991 ·Journal of Pharmacology and Experimental Therapeutics ·Andrew Giovanni, Beth‐Anne Sieber, Richard E. Heikkila, Patricia K. Sonsalla	98
19	Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 1988 ·Proceedings of the National Academy of Sciences ·Richard E. Heikkila, M. Victoria Kindt, Patricia K. Sonsalla, Andrew Giovanni, Stephen K. Youngster, Kathleen A. McKeown, Thomas P. Singer	46
20	Studies with the neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogs 1988 ·Toxicology ·Richard E. Heikkila, Stephen K. Youngster, (unknown), Andrew Giovanni, Patricia K. Sonsalla	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact